Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).
OBJECTIVE: To analyze damage occurring in patients with Wegener's granulomatosis (WG) enrolled in the WG Etanercept Trial (WGET) and to correlate that damage with disease activity, adverse events, and quality of life. METHODS: The Vasculitis Damage Index (VDI) was applied to all 180 patients a...
Hoofdauteurs: | Seo, P, Min, Y, Holbrook, J, Hoffman, G, Merkel, P, Spiera, R, Davis, J, Ytterberg, SR, St Clair, E, McCune, W, Specks, U, Allen, N, Luqmani, R, Stone, J |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
2005
|
Gelijkaardige items
-
Damage from Wegener's granulomatosis and its treatment: Prospective data from the Wegener's granulomatosis Etanercept Trial (WGET).
door: Seo, P, et al.
Gepubliceerd in: (2004) -
Design of the Wegener's Granulomatosis Etanercept Trial (WGET)
door: Stone, J, et al.
Gepubliceerd in: (2002) -
Granulomatosis with polyangiitis (Wegener's): An alternative name for Wegener's granulomatosis
door: Falk, R, et al.
Gepubliceerd in: (2011) -
Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.
door: Falk, R, et al.
Gepubliceerd in: (2011) -
Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.
door: Falk, R, et al.
Gepubliceerd in: (2011)